3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Carcinoma, Renal Cell
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasms
4
Nasopharyngeal Carcinoma
4
Neoplasm Metastasis
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Skin Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Lung Neoplasms
2
Glioblastoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumors
2
von Hippel-Lindau Disease
1
Thyroid cancer, follicular
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Adenocarcinoma
1
Solid Tumors
1
Solid Tumor, Adult
1
Solid Tumor
1
Interventions
Cyclophosphamide
3
regorafenib
2
Proton Therapy
2
Methods
2
Gemcitabine
2
Doxorubicin
2
tocilizumab
1
poly ICLC
1
pembrolizumab
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
flt3 ligand protein
1
endostar protein
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Transcranial Direct Current Stimulation
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Restraint, Physical
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Platinum
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
spartalizumab
×
1 year
×
Clear all
No trials found.